Being brilliant has never been this dangerous…
When Dr Emma Sweeney stumbles across the victim of a hit and run outside Galway University late one evening, she calls her partner, Detective Cormac Reilly, bringing him first to the scene of a murder that would otherwise never have been assigned to him.
A security card in the dead woman’s pocket identifies her as Carline Darcy, a gifted student and heir apparent to Irish pharmaceutical giant Darcy Therapeutics. The multi-billion-dollar company, founded by her grandfather, has a finger in every pie, from sponsoring university research facilities to funding political parties to philanthropy – it has funded Emma’s own ground-breaking research. The enquiry into Carline’s death promises to be high-profile and high pressure.
As Cormac investigates, evidence mounts that the death is linked to a Darcy laboratory and, increasingly, to Emma herself. Cormac is sure she couldn’t be involved, but as his running of the case comes under scrutiny from the department and his colleagues,
Read more on Dervla’s webpage here
I really enjoyed The Ruin, so look forward to reading Dervla’s second book. It sounds fascinating.
Wonderful interview, as usual.
Am reading The Scholar at the moment, got it yesterday and will finish it today. What a great page-turner. As good as The Ruin, which is lovely as sometimes second books are a let-down. I think I know who’s dunnit and why, but it remains to be seen if I’m correct.